Theodore J. Criares

Array ( [id] => 3937451 [patent_doc_number] => 05972917 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-10-26 [patent_title] => '1 .alpha.-hydroxy-25-ene-vitamin D, analogs and uses thereof' [patent_app_type] => 1 [patent_app_number] => 9/087439 [patent_app_country] => US [patent_app_date] => 1998-05-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 9970 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 130 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/972/05972917.pdf [firstpage_image] =>[orig_patent_app_number] => 087439 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4314311 [patent_doc_number] => 06242434 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-06-05 [patent_title] => '24-hydroxyvitamin D, analogs and uses thereof' [patent_app_type] => 1 [patent_app_number] => 9/086969 [patent_app_country] => US [patent_app_date] => 1998-05-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 11614 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 137 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/242/06242434.pdf [firstpage_image] =>[orig_patent_app_number] => 086969 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4089280 [patent_doc_number] => 06133249 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-10-17 [patent_title] => 'Phospholipid and propylene glycol based lubricant' [patent_app_type] => 1 [patent_app_number] => 9/077324 [patent_app_country] => US [patent_app_date] => 1998-05-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 6036 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/133/06133249.pdf [firstpage_image] =>[orig_patent_app_number] => 077324 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1478081 [patent_doc_number] => 06344476 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-02-05 [patent_title] => 'Inhibition of p38 kinase activity by aryl ureas' [patent_app_type] => B1 [patent_app_number] => 09/083396 [patent_app_country] => US [patent_app_date] => 1998-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23390 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 113 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/344/06344476.pdf [firstpage_image] =>[orig_patent_app_number] => 09083396 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3937395 [patent_doc_number] => 05972913 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-10-26 [patent_title] => 'Alendronate therapy to prevent loosening of, or pain associated with, orthopedic implant devices' [patent_app_type] => 1 [patent_app_number] => 9/082237 [patent_app_country] => US [patent_app_date] => 1998-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3017 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/972/05972913.pdf [firstpage_image] =>[orig_patent_app_number] => 082237 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4183464 [patent_doc_number] => 06020374 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-02-01 [patent_title] => 'Biologically active synthetic dye compounds' [patent_app_type] => 1 [patent_app_number] => 9/078495 [patent_app_country] => US [patent_app_date] => 1998-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 16 [patent_no_of_words] => 5779 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/020/06020374.pdf [firstpage_image] =>[orig_patent_app_number] => 078495 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4217241 [patent_doc_number] => 06087349 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-07-11 [patent_title] => 'Method for blocking neoplastic transformation of cells induced by ras oncogenes' [patent_app_type] => 1 [patent_app_number] => 9/081972 [patent_app_country] => US [patent_app_date] => 1998-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3766 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/087/06087349.pdf [firstpage_image] =>[orig_patent_app_number] => 081972 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4141693 [patent_doc_number] => 06060514 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-05-09 [patent_title] => 'Isomer enriched conjugated linoleic acid compositions' [patent_app_type] => 1 [patent_app_number] => 9/072422 [patent_app_country] => US [patent_app_date] => 1998-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5755 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/060/06060514.pdf [firstpage_image] =>[orig_patent_app_number] => 072422 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4273476 [patent_doc_number] => 06323240 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-11-27 [patent_title] => '4-phenyl-4-oxo-butanoic acid derivatives with kynurenine-3-hydroxylase inhibiting activity' [patent_app_type] => 1 [patent_app_number] => 9/068016 [patent_app_country] => US [patent_app_date] => 1998-05-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 13274 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 245 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/323/06323240.pdf [firstpage_image] =>[orig_patent_app_number] => 068016 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1053320 [patent_doc_number] => 06858649 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-02-22 [patent_title] => 'Selective potentiation of serotonin receptor subtypes' [patent_app_type] => utility [patent_app_number] => 09/071389 [patent_app_country] => US [patent_app_date] => 1998-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 12 [patent_no_of_words] => 23390 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 178 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/858/06858649.pdf [firstpage_image] =>[orig_patent_app_number] => 09071389 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4118386 [patent_doc_number] => RE036701 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-05-16 [patent_title] => 'Coronary heart disease treated with oestradiol' [patent_app_type] => 2 [patent_app_number] => 9/069397 [patent_app_country] => US [patent_app_date] => 1998-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2196 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/RE/036/RE036701.pdf [firstpage_image] =>[orig_patent_app_number] => 069397 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4288980 [patent_doc_number] => 06183759 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-02-06 [patent_title] => 'Cosmetic composition' [patent_app_type] => 1 [patent_app_number] => 9/066577 [patent_app_country] => US [patent_app_date] => 1998-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9921 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 156 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/183/06183759.pdf [firstpage_image] =>[orig_patent_app_number] => 066577 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1248554 [patent_doc_number] => 06673831 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-01-06 [patent_title] => 'Combination therapy for reducing the risks associated with cardiovascular disease' [patent_app_type] => B1 [patent_app_number] => 09/067432 [patent_app_country] => US [patent_app_date] => 1998-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4761 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/673/06673831.pdf [firstpage_image] =>[orig_patent_app_number] => 09067432 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1545801 [patent_doc_number] => 06444664 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-09-03 [patent_title] => 'Method for controlling the plasma level of lipoproteins to treat alzheimeris disease' [patent_app_type] => B1 [patent_app_number] => 09/062395 [patent_app_country] => US [patent_app_date] => 1998-04-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3846 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 281 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/444/06444664.pdf [firstpage_image] =>[orig_patent_app_number] => 09062395 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4185974 [patent_doc_number] => 06159997 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-12-12 [patent_title] => 'Treatment of arteriosclerosis and xanthoma' [patent_app_type] => 1 [patent_app_number] => 9/061446 [patent_app_country] => US [patent_app_date] => 1998-04-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10743 [patent_no_of_claims] => 210 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/159/06159997.pdf [firstpage_image] =>[orig_patent_app_number] => 061446 [rel_patent_id] =>[rel_patent_doc_number] =>)